申请人:Pfizer Inc
公开号:US20040259887A1
公开(公告)日:2004-12-23
Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
1
本文描述了作为大麻素受体配体的化合物(I)及其在治疗与动物大麻素受体介导相关的疾病中的用途。